Back to Market Feed

INCRUSE ELLIPTA 62.5 MCG INH

umeclidinium
$10.2684per EA

Strength

62.5 ug/1

NDC

00173087306

Classification

Brand

Dosage Form

AEROSOL, POWDER

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

UMECLIDINIUM BROMIDE

Approval Type

New Drug (NDA)

FDA Application

NDA205382

On Market Since

4/30/2014

Pharmacological Classes

Anticholinergic
Cholinergic Antagonists

Price History

1W

0.0%

1M

+0.1%

3M

+0.0%

6M

+0.1%

1Y

+0.1%

3Y

+0.0%

5Y

+0.0%

All

+17.6%

Generic Alternatives

1 alternative • Same active ingredient

INCRUSE ELLIPTA 62.5 MCG INH
Brand
00173087310•GlaxoSmithKline LLC
$11.3070
+10% more

Related Drugs

Same classification

CUVPOSA 1 MG/5 ML SOLUTION
Brand
00259050116•Merz Pharmaceuticals, LLC
$1.0081
per ML
LOMOTIL 2.5-0.025 MG TABLET
Brand
00025006131•Pfizer Inc.
$3.0028
per EA
MOTOFEN 1-0.025 MG TABLET
Brand
54766020010•Sebela Pharmaceuticals Inc.
$6.9129
per EA
ANORO ELLIPTA 62.5-25 MCG INH
Brand
00173086910•GlaxoSmithKline LLC
$7.8122
per EA
ANORO ELLIPTA 62.5-25 MCG INH
Brand
00173086906•GlaxoSmithKline LLC
$8.0331
per EA
SPIRIVA HANDIHALER 18 MCG CAP
Brand
00597007547•Boehringer Ingelheim Pharmaceuticals Inc.
$10.6188
per EA
SPIRIVA HANDIHALER 18 MCG CAP
Brand
00597007541•Boehringer Ingelheim Pharmaceuticals Inc.
$10.6228
per EA
TRELEGY ELLIPTA 100-62.5-25
Brand
00173088714•GlaxoSmithKline LLC
$11.1502
per EA
TRELEGY ELLIPTA 200-62.5-25
Brand
00173089310•GlaxoSmithKline LLC
$11.1626
per EA
TRELEGY ELLIPTA 100-62.5-25
Brand
00173088710•GlaxoSmithKline LLC
$11.1629
per EA